title: Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes.
abstract: Maleylated bovine serum albumin is a known ligand for targeting macrophages and has potential as a carrier for molecular imaging purposes. We present a novel synthesis of glycolaldehyde-conjugated human serum albumin (GA-HSA) and maleylated human serum albumin (Mal-HSA). Seventeen modifications of fluorescently tagged GA-HSA and Mal-HSA molecules with different degrees of conjugation were prepared. The comparative uptake studies, using 12 of these modifications, were done in vitro on mouse monocytes/macrophages (RAW264.7), and evaluated qualitatively by confocal microscopy and quantitatively by flow cytometry. The GA modifications are taken up by the macrophages approximately 40% better than the maleyl modifications at low concentrations (≤ 3 μM), while at higher concentrations it appears that the maleyl modifications are taken up around 25-44% better than the GA-modified HSA. However, high uptake at low concentrations will be beneficial for in vivo localizing inflammation in areas with low penetration of the probe as in an atherosclerotic plaque. Further, another advantage of GA-HSA is that GA competes less than the maleyl group for the free reactive amine sites that are to be used for conjugation of metal chelating ligands (e.g. tetraazacyclododecanetetraacetic acid and triazacyclononanetriacetic acid). Metal ions such as Gd(3+) and Mn(2+) can be chelated for positive Magnetic Resonance (MR) contrast and positron emitting ions such as (64) Cu(2+) and (68) Ga(3+) for Positron Emission Tomography (PET) imaging. These are important properties, especially, when considering the MR contrast possibilities owing to the low sensitivity of the technique, and would motivate the use of GA-HSA before Mal-HSA.
authors.affiliation: Center for Molecular Medicine, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Björn
authors.initials: B
authors.lastname: Gustafsson
authors.forename: Ulf
authors.initials: U
authors.lastname: Hedin
authors.forename: Kenneth
authors.initials: K
authors.lastname: Caidahl
mesh_terms: D000079:Acetaldehyde / Q000031:analogs & derivatives*; D000818:Animals; D002417:Cattle; D003287:Contrast Media; D006801:Humans; D008264:Macrophages / Q000000981:diagnostic imaging*; D008298:Maleates; D051379:Mice; D057054:Molecular Imaging / Q000379:methods*; D011859:Radiography; D012709:Serum Albumin; D012710:Serum Albumin, Bovine; D000075462:Serum Albumin, Human
chemical_list: D003287:Contrast Media; D008298:Maleates; D012709:Serum Albumin; C078756:maleylated serum albumin, human; D012710:Serum Albumin, Bovine; D000079:Acetaldehyde; C010972:glycolaldehyde; D000075462:Serum Albumin, Human
keywords: MRI; PET; atherosclerosis; cellular targeting; contrast agent; fluorescent probes; glycolaldehyde; human serum albumin; molecular imaging
references.citation: Biochim Biophys Acta. 2008 Feb;1780(2):307-14
references.pmid: 18155175
references.citation: Circulation. 2008 Jun 24;117(25):3206-15
references.pmid: 18541740
references.citation: Radiologe. 2007 Jan;47(1):18-24
references.pmid: 17187263
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1025-30
references.pmid: 19359666
references.citation: N Engl J Med. 1999 Jan 14;340(2):115-26
references.pmid: 9887164
references.citation: Biochem J. 1992 Feb 1;281 ( Pt 3):745-51
references.pmid: 1536652
references.citation: Methods Enzymol. 1972;25:191-9
references.pmid: 23014401
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1017-24
references.pmid: 19359659
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):983-91
references.pmid: 19213945
references.citation: J Interv Cardiol. 2002 Dec;15(6):439-46
references.pmid: 12476646
references.citation: Biochim Biophys Acta. 2007 Dec;1772(11-12):1192-8
references.pmid: 18053692
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):981-2
references.pmid: 19535793
references.citation: Photochem Photobiol. 2000 Oct;72(4):533-40
references.pmid: 11045726
references.citation: J Interv Cardiol. 2003 Jun;16(3):267-72
references.pmid: 12800406
references.citation: Amino Acids. 2003 Dec;25(3-4):283-92
references.pmid: 14661091
references.citation: Circulation. 1994 Aug;90(2):775-8
references.pmid: 8044947
references.citation: Mol Pharm. 2006 Nov-Dec;3(6):654-64
references.pmid: 17140253
references.citation: Diabetes. 2000 Oct;49(10):1714-23
references.pmid: 11016456
references.citation: Int J Immunopathol Pharmacol. 2005 Jul-Sep;18(3):391-402
references.pmid: 16164823
references.citation: J Clin Invest. 2001 Sep;108(5):649-54
references.pmid: 11544267
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1031-8
references.pmid: 19461053
references.citation: Biol Pharm Bull. 1994 Jan;17(1):51-7
references.pmid: 8148817
references.citation: Bioconjug Chem. 2006 Mar-Apr;17(2):538-47
references.pmid: 16536488
references.citation: Nature. 2002 Dec 19-26;420(6917):868-74
references.pmid: 12490960
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1001-8
references.pmid: 19229073
references.citation: Photochem Photobiol Sci. 2008 Jan;7(1):33-9
references.pmid: 18167594
references.citation: N Engl J Med. 2005 Apr 21;352(16):1685-95
references.pmid: 15843671
references.citation: Mol Pharmacol. 2005 Nov;68(5):1423-30
references.pmid: 16105988
references.citation: Semin Thromb Hemost. 2007 Mar;33(2):151-8
references.pmid: 17340463
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1009-16
references.pmid: 19304673
references.citation: J Vasc Surg. 1996 May;23(5):755-65; discussion 765-6
references.pmid: 8667496
references.citation: J Nucl Cardiol. 2008 Jul-Aug;15(4):576-86
references.pmid: 18674725
references.citation: Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):992-1000
references.pmid: 19057023